Design, Synthesis, and Characterization of Novel Iron Chelators: Structure−Activity Relationships of the 2-Benzoylpyridine Thiosemicarbazone Series and Their 3-Nitrobenzoyl Analogues as Potent Antitumor Agents
- 30 June 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 50 (15), 3716-3729
- https://doi.org/10.1021/jm070445z
Abstract
Previously, we demonstrated that the potent antiproliferative activity of the di-2-pyridylketone thiosemicarbazone (DpT) series of Fe chelators was due to their ability to induce Fe depletion and form redox-active Fe complexes (Richardson, D. R.; et al. J. Med. Chem. 2006, 49, 6510−6521). We now examine the role of aromatic substituents on the antiproliferative and redox activity of novel DpT analogues, namely, the 2-benzoylpyridine thiosemicarbazone (BpT) and 2-(3-nitrobenzoyl)pyridine thiosemicarbazone (NBpT) series. Both series exhibited selective antiproliferative effects, with the majority having greater antineoplastic activity than their DpT homologues. This makes the BpT chelators the most active anticancer agents developed within our laboratory. The BpT series Fe complexes exhibit lower redox potentials than their corresponding DpT and NBpT complexes, highlighting their enhanced redox activity. The increased ability of BpT-Fe complexes to catalyze ascorbate oxidation and benzoate hydroxylation, relative to their DpT and NBpT analogues, suggested that redox cycling plays an important role in their antiproliferative activity.Keywords
This publication has 44 references indexed in Scilit:
- Iron chelation and regulation of the cell cycle: 2 mechanisms of posttranscriptional regulation of the universal cyclin-dependent kinase inhibitor p21CIP1/WAF1 by iron depletionBlood, 2007
- Iron chelation regulates cyclin D1 expression via the proteasome: a link to iron deficiency–mediated growth suppressionBlood, 2006
- The Evolution of Iron Chelators for the Treatment of Iron Overload Disease and CancerPharmacological Reviews, 2005
- Delayed Wound Healing in Hemophilia B Mice.Blood, 2005
- N-Picolyl Derivatives of Kemp's Triamine as Potential Antitumor Agents: A Preliminary InvestigationJournal of Medicinal Chemistry, 2005
- Genetic Evidence That CD154 (CD40 Ligand) Plays a Pathophysiologic Role in the Systemic Coagulopathy Associated with Murine Models of Experimental Metastasis and Endotoxemia.Blood, 2004
- The Severe Chronic Neutropenia International Registry - 10 Years of Follow-Up.Blood, 2004
- Potent Antitumor Activity of Novel Iron Chelators Derived from Di-2-Pyridylketone Isonicotinoyl Hydrazone Involves Fenton-Derived Free Radical GenerationClinical Cancer Research, 2004
- Tumor Cell Cytotoxicity of a Novel Metal ChelatorBlood, 1998
- Modulation of cell surface iron transferrin receptors by cellular density and state of activationJournal of Supramolecular Structure, 1979